The Effect of Omega 3 Supplements Comparison With Warm Compression in Patients With Dry Eye Disease

dry eye disease is a common condition characterized by tear film instability and ocular surface inflammation. Omega 3 fatty acid and hot compression are two common tratement for dry eye diseases

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Dry Eye Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

20 year–39 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Benazir Bhutu Hospital

Rawalpindi, Punjab Province, Pakistan

About this study

to investigate the cost effective and efficient treatment for dry eye diseases, During regular visit of patient assessment will be carried out to diagnose disease ,ocular findings and cause of visit .

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Young adults (20-39) years diagnosed with dry eyes and willingness to participate with no ocular surgery and infection from last 2 weeks Children

Exclusion criteria

People having supplements
Patients having diet with omega 3 for 1 month
Patients who has undergone glaucoma treatment
Already receiving treatment of dry eyes
Patients with any ocular surgery

Treatment and study plan

group 1

Diagnostic Test

To determine the optimal treatment for dry eyes in term of cost effectiveness and time efficiency by comparing omega 3 supplements versus warm compression

Primary outcomes

OSDI

Time frame: 12 Months

The OSDI score was grouped as per the following: normal (0-12 points), mild (13-22 points), moderate (23-32 points), and severe (33-100 points) [7]. Grouping for the number of years smoking was done in the following way: < 1 year, 1-5 years, 6-10 years, 11-15 years, 16-20 years, and 20+ years.

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2025
First posted: Dec 27, 2024
Registry last updated: Dec 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting